Fibroscan
Fibroscan is an intervention with 56 clinical trials. Currently 13 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
84.2%
16 of 19 finished
15.8%
3 ended early
13
trials recruiting
56
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Liver Biomarkers in Anorexia Nervosa
FibroScan-Reproducibility and Repeatability Study
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Milk Thistle Clinical Trial in Pediatric NAFLD
Prevalence of NAFLD in T2DM Patients
Clinical Trials (56)
Liver Biomarkers in Anorexia Nervosa
FibroScan-Reproducibility and Repeatability Study
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Milk Thistle Clinical Trial in Pediatric NAFLD
Prevalence of NAFLD in T2DM Patients
Fibroscan Study in HCC
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Endoscopic Ultrasound Shear Wave Elastography Study
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
Fatty Liver and Pancreatic Steatosis
Prevalence of NAFLD in T1DM Patients
Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation
Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital
Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 56